Insmed Inc (INSM)vsVBI Vaccines Inc (VBIV)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
VBIV
VBI Vaccines Inc
$0.07
0.00%
HEALTHCARE · Cap: $1.87M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 6344% more annual revenue ($606.42M vs $9.41M). VBIV leads profitability with a 0.0% profit margin vs -2.1%. VBIV earns a higher WallStSmart Score of 40/100 (D).
INSM
Hold39
out of 100
Grade: F
VBIV
Hold40
out of 100
Grade: D
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
1.5% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : VBIV
VBIV has a balanced fundamental profile.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : VBIV
The primary concerns for VBIV are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while VBIV is a value play — different risk/reward profiles.
VBIV carries more volatility with a beta of 2.17 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
VBIV generates stronger free cash flow (-12M), providing more financial flexibility.
Bottom Line
VBIV scores higher overall (40/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
VBI Vaccines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?